| Date Filed | Type | Description |
| 10/06/2023 |
4
| Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Paid exercise price by delivering 52 shares
@ $16.01, valued at
$832.5
Exercised 175 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 20,459 options to buy
@ $10.76, valued at
$220.1k
Granted 10,230 options to buy
@ $0 |
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
4
| Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 703 shares
@ $9.56, valued at
$6.7k
Paid exercise price by delivering 228 shares
@ $11.44, valued at
$2.6k
Granted 31,460 options to buy
@ $11.97, valued at
$376.6k
Granted 15,730 options to buy
@ $0
Exercised 775 options to buy
@ $0 |
|
| 04/11/2022 |
4
| Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 31,460 options to buy
@ $11.1, valued at
$349.2k
Granted 15,730 options to buy
@ $0 |
|
| 03/23/2022 |
4
| Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Paid exercise price by delivering 1,120 shares
@ $10.98, valued at
$12.3k
Exercised 3,231 options to buy
@ $0 |
|
| 03/18/2022 |
4
| Megna Michael R (Chief Accounting Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 641 shares
@ $9.51, valued at
$6.1k
Granted 405 shares
@ $15.02, valued at
$6.1k
Granted 588 shares
@ $11.49, valued at
$6.8k
Granted 653 shares
@ $9.63, valued at
$6.3k
Paid exercise price by delivering 269 shares
@ $10.13, valued at
$2.7k
Exercised 775 options to buy
@ $0 |
|
| 10/06/2021 |
4
| Megna Michael R (Chief Accounting Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 700 options to buy
@ $0 |
|
| 09/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2020 |
4
| Megna Michael R (Chief Accounting Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 19,000 options to buy
@ $15.5, valued at
$294.5k
|
|
| 03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/10/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/26/2010 |
4
| Megna Michael R (Chief Accounting Officer) has filed a Form 4 on BIOSPHERE MEDICAL INC|
Txns:
| Granted 18,600 shares
@ $0.01, valued at
$186 |
|